Steven Bernstein
Analyst · Pareto Ventures. George, your line is live
Thank you, Tom, and good afternoon. For the nine months ended January 31, 2025, consolidated revenue was $49.8 million compared to $39.7 million for the same period of the prior fiscal year. The components of revenue are as follows. Revenue from commercial and U.S. government satellite programs was approximately $28.8 million, or 58%, compared to $16.3 million, or 41%, in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI New York segment. Revenues from non-space U.S. government and DoD customers, which are recorded in both the FEI New York and FEI-Zyfer segments, were $19.5 million compared to $21.1 million in the same period of the prior fiscal year and accounted for approximately 39% of consolidated revenue compared to 53% for the prior fiscal year. Other commercial and industrial revenues were $1.5 million and $2.3 million for the nine months ending January 31, 2025, and 2024, respectively. The significant increase in revenue for the period was primarily related to an increase in U.S. government customer sales for satellite programs. For the nine months ending January 31, 2025, gross margin and gross margin rate increased as compared to the same period in fiscal year 2024. This is partially due to a large space program that completed major milestones during the nine months ended January 31, 2025, as well as other legacy programs performing well. For the nine months ending January 31, 2025, and 2024, SG&A expenses were approximately 19% of consolidated revenues in each period. The increase in SG&A expenses during the nine months ending January 31, 2025, was mainly related to an increase in payroll related expenses, including stock compensation, incentive approvals based on company performance, costs from the realignment of employees from overhead to SG&A, and the costs related to Frequency Electronics first Quantum Summit in October 2024. The company believes the costs related to SG&A will remain fairly constant throughout the remainder of the fiscal year 2025. R&D expense for the nine months ending January 31, 2025, increased to $4.5 million from $2.3 million, an increase of $2.2 million, and were approximately 9% and 6% respectively of consolidated revenue. The change in R&D expenditures for the nine months ending January 31, 2025, as compared to prior year periods, was primarily due to a focus on advances and modernization of products. The company plans to continue to invest in R&D in the future to keep its products at the state-of-the-art. However, we expect the actual quarterly spend to vary. For the nine months ending January 2025, the company recorded an operating income of $8.5 million compared to an operating income of $2.5 million in the prior year. The increase is partially due to a large space program that completed major milestones in its production during the nine months ending January 31, 2025, as discussed above. However, the increase also is the result of successful efforts of the company to complete complex programs and to work more efficiently in bidding, building and testing our products. The company believes the improved operating income results for the first nine months of the fiscal year are a tangible outcome of these efforts. The company seeks to continue to implement changes to further improve its performance. Other income can be derived from reclaiming of metals, refunds, interest on deferred trust assets or sale of fixed assets. Interest expense is related to the deferred compensation payments made to retired employees. This yields pre-tax income of approximately $8.9 million compared to $3 million for the prior fiscal year. As for the tax provision, the company weighed all available positive and negative evidence and it's more likely than not Q3 2025 deferred tax asset realization assessment. Frequency no longer has cumulative losses in recent years and has earnings in the three and nine months ended January 31, 2025. The company is utilizing its operating loss carry-forwards and is reducing its net deferred tax asset. For the nine months ending January 31, 2025, the company recorded an income tax benefit of $11.6 million, which includes a discrete tax benefit of $11.9 million. The calculation of the overall income tax provision consists of a discrete tax benefit for the release of the valuation allowance offset by current U.S. federal and state income taxes. For the nine months ending January 31, 2024, the company recorded an income tax provision of 19,000. Consolidated net income for the nine months ending January 31, 2025 was $20.5 million or $2.18 per share compared to $3 million or $0.32 per share in the previous fiscal year. Our fully-funded backlog at the end of January 2025 was approximately $73 million compared to approximately $78 million for the previous fiscal year end April 30, 2024. The company's balance sheet continues to reflect a strong working capital position of approximately $27 million at January 31, 2025 and a current ratio of approximately 2.2 to 1. Cash went down by approximately $12.8 million since year-end of this decrease, the dividend paid in Q2 accounted for approximately $9.6 million. The additional $3.2 million decrease was related to timing of billings and revenue. Contract liabilities went down $7.4 million quarter-over-quarter and $6.4 million since year end. Contract liabilities are generated as part of the 606 accounting when the billings are in excess of revenue taken on specific programs. We expect that cash will fluctuate quarter-to-quarter, however, we expect it to trend higher over time. Additionally, the company is debt free. The company believes that its liquidity is adequate to meet its operating investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom and we look forward to your questions.